Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Digene
New activities and developments reported by Digene
February 14th, 2007
New activities and developments reported by Digene. This trend article is an immediate alert from NewsRx to identify the most recent news developments at Digene. Report 1: Four Spanish medical societies have published national consensus cervical cancer prevention guidelines that recommend HPV DNA testing for routine, primary screening for women over 35, Digene Corp. announced. In addition to HPV DNA testing for primary screening, the guidelines also recommend use of the test for "proof of cure" following treatment, as well as for follow-up evaluation of women with inconclusive Pap results. The Digene HPV test, which uses the...
Source: Medical Patent Law Weekly (2007-02-14)
|
